Outpatient follow‐up and rehospitalizations for sickle cell disease patients

Rehospitalization rates are increasingly used as quality indicators for a variety of illnesses, including sickle cell disease. While one small, single center study suggested outpatient follow‐up with a pediatric hematologist was associated with fewer rehospitalizations, no study has examined the effect of post‐discharge outpatient follow‐up on rehospitalization rates across ages and beyond a single site.

[1]  E Vichinsky,et al.  Pain in sickle cell disease. Rates and risk factors. , 1991, The New England journal of medicine.

[2]  T. Koepsell,et al.  Provision of pneumococcal prophylaxis for publicly insured children with sickle cell disease. , 2003, JAMA.

[3]  Melissa J. Frei-Jones,et al.  Multi‐modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30‐day readmission rate , 2009, Pediatric blood & cancer.

[4]  P. Arbogast,et al.  Medical care utilization and mortality in sickle cell disease: A population‐based study , 2005, American journal of hematology.

[5]  M. DeBaun,et al.  Asthma is associated with increased mortality in individuals with sickle cell anemia. , 2007, Haematologica.

[6]  J. Scott,et al.  Variation in hospitalizations and hospital length of stay in children with vaso‐occlusive crises in sickle cell disease , 2005, Pediatric blood & cancer.

[7]  S. Ballas,et al.  Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance , 2005, American journal of hematology.

[8]  Y. M. Yang,et al.  Comparison of costs to the health sector of comprehensive and episodic health care for sickle cell disease patients. , 1995, Public health reports.

[9]  S. Gortmaker,et al.  Who cares for medicaid-enrolled children with chronic conditions? , 2001, Pediatrics.

[10]  S. Davies,et al.  Acute admissions of patients with sickle cell disease who live in Britain. , 1987, British medical journal.

[11]  M. DeBaun,et al.  Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia. , 2006, Blood.

[12]  E. Sondik,et al.  Status of Childhood Asthma in the United States, 1980–2007 , 2009, Pediatrics.

[13]  D. Webb,et al.  Diagnosing Diabetes and Preventing Rehospitalizations: The Urban Diabetes Study , 2006, Medical care.

[14]  Mark V. Williams,et al.  Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[15]  Stephen A. Martin,et al.  A Reengineered Hospital Discharge Program to Decrease Rehospitalization , 2009, Annals of Internal Medicine.

[16]  C. Quinn.  A question of quality in sickle cell disease , 2009, Pediatric blood & cancer.

[17]  M. DeBaun,et al.  Asthma and sickle cell disease: two distinct diseases or part of the same process? , 2009, Hematology. American Society of Hematology. Education Program.

[18]  Pamela L Owens,et al.  Acute care utilization and rehospitalizations for sickle cell disease. , 2010, JAMA.

[19]  J. Field,et al.  Risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease , 2009, Pediatric blood & cancer.

[20]  J. Scott,et al.  Health‐related quality of life in children with sickle cell disease: child and parent perception , 2005, British journal of haematology.

[21]  K. Harjai,et al.  Simple clinical variables are markers of the propensity for readmission in patients hospitalized with heart failure. , 2001, The American journal of cardiology.

[22]  Richard E. Rohr,et al.  Rehospitalizations among patients in the Medicare fee-for-service program. , 2009, The New England journal of medicine.

[23]  E. Schwalenstocker,et al.  Appropriate use of quality measures: Response to “risk factors for hospital readmission within 30 days: A new quality measure for children with sickle cell disease” , 2009, Pediatric blood & cancer.

[24]  R. Olney.  Preventing morbidity and mortality from sickle cell disease. A public health perspective. , 1999, American journal of preventive medicine.

[25]  P. Kavanagh,et al.  Sickle cell disease-related pediatric medical expenditures in the U.S. , 2010, American journal of preventive medicine.

[26]  H. Bauchner,et al.  Socioeconomic status and length of hospital stay in children with vaso-occlusive crises of sickle cell disease. , 2007, Journal of the National Medical Association.